Effects of a multispecies probiotic mixture on glycemic control and inflammatory status in women with gestational diabetes: A randomized controlled clinical trial

Journal of Nutrition and Metabolism

Volumn 2016, Issue , 2016, Pages

  Jafarnejad, Sadegh ^a   Saremi, Sadaf ^b   Jafarnejad, Farzan ^c   Arab, Arman ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84982840887     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2016/5190846     Document Type: Article

References (45)

1. P. Sreelakshmi, S. Nair, B. Soman, R. Alex, K. Vijayakumar, and V. Kutty, Maternal, and neonatal outcomes of gestational diabetes: a retrospective cohort study from Southern India, Journal of Family Medicine, and Primary Care, vol. 4, no. 3, p. 395, 2015.
2. D. B. Carr, K.M.Newton, K.M.Utzschneider, et al., Gestational diabetes or lesser degrees of glucose intolerance, and risk of preeclampsia, Hypertension in Pregnancy, vol. 30, no. 2, pp. 153-163, 2011.
3. J. C. Dempsey, Z. Ashiny, C.-F. Qiu, R. S. Miller, T. K. Sorensen, andM. A.Williams, Maternalpre-pregnancyoverweight status, and obesity as risk factors for cesarean delivery, The Journal of Maternal-Fetal andNeonatalMedicine, vol. 17, no. 3, pp. 179-185, 2005.
4. M. D. Nitert, H. L. Barrett, K. Foxcroft, et al., SPRING: an RCTstudy of probiotics in the prevention of gestational diabetes mellitus in overweight, and obese women, BMC Pregnancy, and Childbirth, vol. 13, article 50, 2013.
5. E.M.Wendland, M. R. Torloni, M. Falavigna, et al., Gestational diabetes, and pregnancy outcomes-A systematic review of the World Health Organization (WHO), and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria, BMC Pregnancy, and Childbirth, vol. 12, article 23, 2012.
6. L. L. Lipscombe, A. T. Banerjee, S.McTavish, et al., Readiness for diabetes prevention, and barriers to lifestyle change in women with a history of gestational diabetes mellitus: rationale, and study design, Diabetes Research, and Clinical Practice, vol. 106, no. 1, pp. 57-66, 2014.
7. S. P. Palem, and P. Abraham, A study on the level of oxidative stress, and inflammatory markers in type 2 diabetes mellitus patients with different treatment modalities, Journal of Clinical, and Diagnostic Research, vol. 9, no. 9, pp. BC04-BC07, 2015.
8. M. Blaser, Antibiotic overuse: stop the killing of beneficial bacteria, Nature, vol. 476, no. 7361, pp. 393-394, 2011.
9. G. D. Wu, J. Chen, C. Hoffmann, et al., Linking long-Term dietary patterns with gut microbial enterotypes, Science, vol. 334, no. 6052, pp. 105-108, 2011.
10. R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, Microbial ecology: human gut microbes associated with obesity, Nature, vol. 444, no. 7122, pp. 1022-1023, 2006.
11. M. G. Redman, E. J.Ward, and R. S. Phillips, The efficacy, and safety of probiotics in people with cancer: a systematic review, Annals of Oncology, vol. 25, no. 10, pp. 1919-1929, 2014.
12. G. Reid, J. Jass, M. T. Sebulsky, and J. K.McCormick, Potential uses of probiotics in clinical practice, Clinical Microbiology Reviews, vol. 16, no. 4, pp. 658-672, 2003.
13. P.Gionchetti, F. Rizzello, A.Venturi, et al., Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterology, vol. 119, no. 2, pp. 305-309, 2000.
14. R. K. Dhiman, B. Rana, S. Agrawal, et al., Probiotic VSL#3 reduces liver disease severity, and hospitalization in patients with cirrhosis: a randomized, controlled trial, Gastroenterology, vol. 147, no. 6, pp. 1327-1337.e3, 2014.
15. R. N. Fedorak, B. G. Feagan, N. Hotte, et al., The probiotic vsl#3 has anti-inflammatory effects, and could reduce endoscopic recurrence after surgery for Crohn's disease, Clinical Gastroenterology, and Hepatology, vol. 13, no. 5, pp. 928-935.e2, 2015.
16. P. Mastromarino, D. Capobianco, A. Miccheli, et al., Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery, Pharmacological Research, vol. 95-96, pp. 63-70, 2015.
17. S. Rohatgi, V. Ahuja, G. K.Makharia, et al., VSL#3 induces, and maintains short-Term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial, BMJ Open Gastroenterology, vol. 2, no. 1, Article ID e000018, 2015.
18. S. J. Allen, S. Jordan, M. Storey, et al., Dietary supplementation with lactobacilli, and bifidobacteria is well tolerated, and not associated with adverse events during late pregnancy, and early infancy, Journal of Nutrition, vol. 140, no. 3, pp. 483-488, 2010.
19. Z. Asemi, M. Samimi, Z. Tabassi, et al., Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial, European Journal of Clinical Nutrition, vol. 67, no. 1, pp. 71-74, 2013.
20. L. Hoffman, C. Nolan, J. D. Wilson, J. J. N. Oats, and D. Simmons, Gestational diabetesmellitus-management guidelines. The Australasian diabetes in pregnancy society, The Medical Journal of Australia, vol. 169, no. 2, pp. 93-97, 1998.
21. American Diabetes Association, Diagnosis, and classification of diabetes mellitus, Diabetes Care, vol. 33, supplement 1, pp. S62-S69, 2009.
22. M. Ljungberg, R. Korpela, J. Ilonen, J. Ludvigsson, and O. Vaarala, Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes-The PRODIA study, Annals of the New York Academy of Sciences, vol. 1079, pp. 360-364, 2006.
23. T. Yamano, M. Tanida, A. Niijima, et al., Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves, and blood glucose in rats, Life Sciences, vol. 79, no. 20, pp. 1963-1967, 2006.
24. P. D. Cani, S. Possemiers, T. Van de Wiele, et al., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, Gut, vol. 58, no. 8, pp. 1091-1103, 2009.
25. J. Ilmonen, E. Isolauri, T. Poussa, and K. Laitinen, Impact of dietary counselling, and probiotic intervention on maternal anthropometric measurements during, and after pregnancy: a randomized placebo-controlled trial, ClinicalNutrition, vol. 30, no. 2, pp. 156-164, 2011.
26. K. L. Lindsay, M. Kennelly, M. Culliton, et al., Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study), The American Journal of Clinical Nutrition, vol. 99, no. 6, pp. 1432-1439, 2014.
27. K. L. Lindsay, L. Brennan, M. A. Kennelly, et al., Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial, American Journal of Obstetrics, and Gynecology, vol. 212, no. 4, pp. 496.e1-496.e11, 2015.
28. J. K. Collins, C. Dunne, L. Murphy, et al., A randomised controlled trial of a probiotic Lactobacillus strain in healthy adults: assessment of its delivery, transit, and influence on microbial flora, and enteric immunity, Microbial Ecology in Health, and Disease, vol. 14, no. 2, pp. 81-89, 2002.
29. S. Tachon, B. Lee, and M. L. Marco, Diet alters probiotic Lactobacillus persistence, and function in the intestine, Environmental Microbiology, vol. 16, no. 9, pp. 2915-2926, 2014.
30. E. S. Yeo, J. Y. Hwang, J. E. Park, Y. J. Choi, K. B. Huh, and W. Y. Kim, Tumor necrosis factor (TNF-α), and c-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes, YonseiMedical Journal, vol. 51, no. 4, pp. 519-525, 2010.
31. B. Garcia-Bailo, A. El-Sohemy, P. S. Haddad, et al., Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation, and oxidative stress, Biologics: Targets &Therapy, vol. 5, pp. 7-19, 2011.
32. T. Matsuzaki, R. Yamazaki, S. Hashimoto, and T. Yokokura, Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-A(y) mice, Endocrine Journal, vol. 44, no. 3, pp. 357-365, 1997.
33. S. Twetman, B. Derawi, M. Keller, K. Ekstrand, T. Yucel-Lindberg, and C. Stecksén-Blicks, Short-Termeffect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid, Acta Odontologica Scandinavica, vol. 67, no. 1, pp. 19-24, 2009.
34. Z. Mazloom, A. Yousefinejad, and M. H. Dabaghmanaesh, Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial, Iranian Journal of Medical Sciences, vol. 38, no. 1, pp. 38-43, 2013.
35. M. Mohamadshahi, M. Veissi, F. Haidari, H. Shahbazian, G.-A. Kaydani, and F. Mohammadi, Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes, BioImpacts, vol. 4, no. 2, pp. 83-88, 2014.
36. Z. Asemi, S. Jazayeri, M. Najafi, et al., Effect of daily consumption of probiotic yogurt on oxidative stress in pregnant women: a randomized controlled clinical trial, Annals of Nutrition, and Metabolism, vol. 60, no. 1, pp. 62-68, 2012.
37. K. Hatakka, J. Martio, M. Korpela, et al., Effects of probiotic therapy on the activity, and activation of mild rheumatoid arthritis-A pilot study, Scandinavian Journal of Rheumatology, vol. 32, no. 4, pp. 211-215, 2003.
38. S. Asemi, S. Jazayeri, M. Najafi, et al., Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial, Pakistan Journal of Biological Sciences, vol. 14, no. 8, pp. 476-482, 2011.
39. N. Larsen, F. K. Vogensen, F. W. J. van den Berg, et al., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults, PLoS ONE, vol. 5, no. 2, Article ID e9085, 2010.
40. I.Nadal, A. Santacruz, A.Marcos, et al., Shifts in clostridia, bacteroides, and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents, International Journal of Obesity, vol. 33, no. 7, pp. 758-767, 2009.
41. A. Santacruz, A.Marcos, J.Wärnberg, et al., Interplay between weight loss, and gut microbiota composition in overweight adolescents, Obesity, vol. 17, no. 10, pp. 1906-1915, 2009.
42. X. Wu, C. Ma, L. Han, et al., Molecular characterisation of the faecal microbiota in patients with type II diabetes, Current Microbiology, vol. 61, no. 1, pp. 69-78, 2010.
43. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, TLR4 links innate immunity, and fatty acid-induced insulin resistance, The Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015-3025, 2006.
44. J.-H. Lee, B. Lee, H.-S. Lee, et al., Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression, and TLR-4-linked NF-kB activation in experimental colitis, International Journal of Colorectal Disease, vol. 24, no. 2, pp. 231-237, 2009.
45. X.-Z. Shi, P. F. Lindholm, and S. K. Sarna, NF-kB activation by oxidative stress, and inflammation suppresses contractility in colonic circular smoothmuscle cells, Gastroenterology, vol. 124, no. 5, pp. 1369-1380, 2003.